InsiderTrades

Form 4 for LMAT LEMAITRE VASCULAR INC

Accepted 2024-03-04 00:00:00 ET · period of report 2024-02-29 · accession 0001437749-24-006515 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-04 2024-02-29 LMAT Jasinski Lawrence J Dir A - Grant $0.00 +593 10.4K +6% $0
D 2024-03-04 2024-02-29 LMAT Jasinski Lawrence J Dir M - OptEx $0.00 +1 10.4K +0.0% $0
D 2024-03-04 2024-02-29 LMAT Jasinski Lawrence J Dir M - OptEx $0.00 -1.99 4 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-29 A A 593 $0.00 10,418 D — — (F1) These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 1/3 upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next two years. (F2) Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals.
2 Common Common Stock 2024-02-29 M A 1 $0.00 10,419 D — — (F3) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
3 Derivative Dividend Equivalent Rights 2024-02-29 M D 1.99 $0.00 4 D — · — to — 1.99 Common Stock (F4) These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.